Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin.
David
Miruna D
MD
Gill
Martin J
MJ
D000151:Acinetobacter Infections / Q000188:drug therapy*; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000302:isolation & purification; D000328:Adult; D002056:Burns / Q000150:complications; D003091:Colistin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D009154:Mutation
C004691:colistinmethanesulfonic acid; D003091:Colistin